Filing Flows › Maravai Lifesciences Holdings (MRVI) › Q3 2026 › vs Q3 2025
Maravai Lifesciences Holdings (MRVI) Q3 2026 vs Q3 2025 (year over year)
Maravai Lifesciences Holdings's revenue rose $4.2M (+10%) from $41.6M in Q3 2025 to $45.9M in Q3 2026. The biggest changes: TriLink +$3.0M (+12%); Cygnus +$1.2M (+8%).
Maravai Lifesciences Holdings, Q3 2026: revenue $45.9M (+10% year over year), operating margin -45.0%, net loss $24.0M, operating cash flow $5.0M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 9.8% | -43.4% | +53.2 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| TriLink | $28.4M | $25.4M | $3.0M | +12% |
| Cygnus | $17.5M | $16.3M | $1.2M | +8% |
| Revenue | $45.9M | $41.6M | $4.2M | +10% |
| Income tax benefit | $75K | $92K | −$17K | -18% |
| Net loss | $24.0M | $45.1M | −$21.1M | -47% |
| Costs & expenses | $69.9M | $86.8M | −$16.9M | -19% |
| Operating costs | $66.5M | $82.7M | −$16.2M | -20% |
| Interest & other, net | $3.5M | $4.1M | −$662K | -16% |
| Cost of revenue | $29.7M | $36.0M | −$6.3M | -18% |
| Research & development | $3.4M | $3.8M | −$454K | -12% |
| SG&A | $30.5M | $35.5M | −$5.0M | -14% |
| Other operating costs | $2.9M | $7.4M | −$4.5M | -60% |
| Operating cash sources | $29.0M | $29.9M | −$892K | -3% |
| Depreciation & amortization | $12.2M | $13.2M | −$981K | -7% |
| Share-based compensation | $10.1M | $9.1M | $1.1M | +12% |
| Working capital & other | $6.7M | $7.7M | −$970K | -13% |
| Net loss absorbed | $24.0M | $45.1M | −$21.1M | -47% |
| Operating cash flow | $5.0M | −$15.2M | $20.2M | — |
| Free cash flow (OCF − capex) | $4.5M | −$18.1M | $22.6M | — |
| Capital expenditures | $523K | $2.9M | −$2.4M | -82% |
Questions
How much did Maravai Lifesciences Holdings's revenue grow year over year in Q3 2026?
Maravai Lifesciences Holdings's revenue rose $4.2M (+10%) from $41.6M in Q3 2025 to $45.9M in Q3 2026.
What drove Maravai Lifesciences Holdings's revenue change in Q3 2026?
TriLink +$3.0M (+12%); Cygnus +$1.2M (+8%).